Farallon Capital Management as of March 31, 2020
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 97 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allergan | 14.4 | $1.6B | 9.3M | 177.10 | |
| Spdr S&p 500 Etf (SPY) | 6.3 | $722M | 2.6M | 275.75 | |
| Fidelity National Information Services (FIS) | 4.9 | $562M | 4.6M | 121.64 | |
| Centene Corporation (CNC) | 3.8 | $431M | 7.3M | 59.41 | |
| Iqvia Holdings (IQV) | 3.5 | $403M | 3.7M | 107.86 | |
| Thermo Fisher Scientific (TMO) | 3.1 | $353M | 1.2M | 283.60 | |
| Alphabet Inc Class C cs (GOOG) | 3.0 | $343M | 295k | 1162.81 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 2.8 | $316M | 723k | 436.31 | |
| IAC/InterActive | 2.7 | $307M | 1.7M | 179.23 | |
| Abbvie (ABBV) | 2.7 | $305M | 4.0M | 76.19 | |
| Wabtec Corporation (WAB) | 2.7 | $304M | 6.3M | 48.13 | |
| Ihs Markit | 2.6 | $296M | 4.9M | 60.00 | |
| Microsoft Corporation (MSFT) | 2.5 | $288M | 1.8M | 157.71 | |
| Visa (V) | 2.5 | $284M | 1.8M | 161.12 | |
| Anthem (ELV) | 2.5 | $284M | 1.3M | 227.04 | |
| General Dynamics Corporation (GD) | 2.4 | $276M | 2.1M | 132.31 | |
| Sherwin-Williams Company (SHW) | 2.0 | $234M | 509k | 459.52 | |
| salesforce (CRM) | 2.0 | $233M | 1.6M | 143.98 | |
| Cigna Corp (CI) | 1.9 | $222M | 1.3M | 177.18 | |
| Alibaba Group Holding (BABA) | 1.9 | $219M | 1.1M | 194.48 | |
| Acceleron Pharma | 1.7 | $196M | 2.2M | 89.87 | |
| Facebook Inc cl a (META) | 1.6 | $181M | 1.1M | 166.80 | |
| Equinix (EQIX) | 1.5 | $176M | 282k | 624.57 | |
| Exelixis (EXEL) | 1.5 | $172M | 10M | 17.22 | |
| Iovance Biotherapeutics (IOVA) | 1.5 | $172M | 5.8M | 29.93 | |
| Alnylam Pharmaceuticals (ALNY) | 1.4 | $163M | 1.5M | 108.85 | |
| Palo Alto Networks (PANW) | 1.4 | $162M | 987k | 163.96 | |
| Ascendis Pharma A S (ASND) | 1.4 | $155M | 1.4M | 112.61 | |
| Transunion (TRU) | 1.2 | $134M | 2.0M | 66.18 | |
| Rts/bristol-myers Squibb Compa | 1.2 | $134M | 35M | 3.80 | |
| Forty Seven | 0.9 | $105M | 1.1M | 95.42 | |
| Enanta Pharmaceuticals (ENTA) | 0.8 | $90M | 1.8M | 51.43 | |
| Broadmark Rlty Cap | 0.6 | $72M | 9.6M | 7.52 | |
| Ra Pharmaceuticals | 0.6 | $69M | 1.4M | 48.01 | |
| Fate Therapeutics (FATE) | 0.6 | $67M | 3.0M | 22.21 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.5 | $63M | 3.1M | 20.14 | |
| Zymeworks | 0.5 | $62M | 1.8M | 35.47 | |
| Zogenix | 0.5 | $56M | 2.3M | 24.73 | |
| Fibrogen | 0.5 | $56M | 1.6M | 34.75 | |
| Apellis Pharmaceuticals (APLS) | 0.5 | $54M | 2.0M | 26.79 | |
| Playa Hotels & Resorts Nv (PLYA) | 0.5 | $54M | 31M | 1.75 | |
| Karyopharm Therapeutics Inc note 3.000%10/1 | 0.4 | $50M | 35M | 1.41 | |
| Mirati Therapeutics | 0.4 | $46M | 600k | 76.87 | |
| Equifax (EFX) | 0.4 | $45M | 378k | 119.45 | |
| Agios Pharmaceuticals (AGIO) | 0.4 | $44M | 1.3M | 35.48 | |
| Ptc Therapeutics Inc conv bd us | 0.4 | $43M | 40M | 1.07 | |
| Deciphera Pharmaceuticals | 0.4 | $41M | 1.0M | 41.17 | |
| Karuna Therapeutics Ord | 0.4 | $41M | 567k | 72.00 | |
| United Therapeutics Corporation (UTHR) | 0.3 | $35M | 365k | 94.82 | |
| Sarepta Therapeutics (SRPT) | 0.3 | $34M | 350k | 97.82 | |
| Veracyte (VCYT) | 0.3 | $33M | 1.4M | 24.31 | |
| Progenics Pharmaceuticals | 0.3 | $31M | 8.3M | 3.80 | |
| Clovis Oncology Inc note 1.250% 5/0 | 0.3 | $31M | 49M | 0.62 | |
| Cara Therapeutics | 0.3 | $30M | 2.3M | 13.21 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.3 | $29M | 1.0M | 28.77 | |
| Avrobio Ord (AVRO) | 0.2 | $27M | 1.7M | 15.56 | |
| Radius Health | 0.2 | $27M | 2.1M | 13.00 | |
| Zealand Pharma A/s- | 0.2 | $26M | 750k | 34.50 | |
| Karyopharm Therapeutics | 0.2 | $26M | 1.3M | 19.21 | |
| Invitae (NVTAQ) | 0.2 | $26M | 1.9M | 13.67 | |
| Momenta Pharmaceuticals | 0.2 | $23M | 843k | 27.20 | |
| Principia Biopharma | 0.2 | $23M | 385k | 59.38 | |
| Intercept Pharmaceuticals In Note 2.000 5/1 bnd | 0.2 | $23M | 26M | 0.88 | |
| Tricida | 0.2 | $22M | 1.0M | 22.00 | |
| Myokardia | 0.2 | $20M | 430k | 46.88 | |
| Sage Therapeutics (SAGE) | 0.2 | $19M | 675k | 28.72 | |
| Blackstone Group Inc Com Cl A (BX) | 0.2 | $18M | 403k | 45.57 | |
| Theravance Biopharma Inc note 3.250%11/0 | 0.1 | $16M | 16M | 0.96 | |
| Crispr Therapeutics (CRSP) | 0.1 | $15M | 350k | 42.41 | |
| Amarin Corporation | 0.1 | $15M | 3.6M | 4.00 | |
| Atara Biotherapeutics | 0.1 | $13M | 1.5M | 8.51 | |
| Uniqure Nv (QURE) | 0.1 | $12M | 250k | 47.45 | |
| D Stemline Therapeutics | 0.1 | $11M | 2.4M | 4.84 | |
| Krystal Biotech (KRYS) | 0.1 | $11M | 250k | 43.24 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $11M | 1.5M | 7.06 | |
| Savara (SVRA) | 0.1 | $10M | 4.8M | 2.12 | |
| Quotient | 0.1 | $9.9M | 2.5M | 3.95 | |
| Verastem | 0.1 | $9.8M | 3.7M | 2.64 | |
| Akebia Therapeutics (AKBA) | 0.1 | $9.5M | 1.3M | 7.58 | |
| Pacific Biosciences of California (PACB) | 0.1 | $9.2M | 3.0M | 3.06 | |
| Ready Cap Corp Com reit (RC) | 0.1 | $9.2M | 1.3M | 7.22 | |
| Cytokinetics (CYTK) | 0.1 | $7.4M | 625k | 11.79 | |
| Dermtech Ord ord (DMTKQ) | 0.1 | $6.8M | 605k | 11.25 | |
| Radius Health Inc note 3.000% 9/0 | 0.0 | $4.8M | 6.8M | 0.71 | |
| Optinose | 0.0 | $3.5M | 781k | 4.49 | |
| Beam Therapeutics (BEAM) | 0.0 | $3.1M | 170k | 18.00 | |
| Xerox Corp (XRX) | 0.0 | $2.5M | 130k | 18.94 | |
| Ctrip Com Intl Ltd note 1.990% 7/0 | 0.0 | $2.0M | 2.0M | 0.99 | |
| Ctrip Com Intl Ltd Note 1.000% 7/0 bond | 0.0 | $1.9M | 2.0M | 0.97 | |
| Applied Genetic Technol Corp C | 0.0 | $1.9M | 587k | 3.28 | |
| Broadmark Rlty Cap Inc *w exp 11/15/202 | 0.0 | $1.6M | 7.2M | 0.22 | |
| Intercept Pharmas conv | 0.0 | $1.2M | 1.5M | 0.81 | |
| Gossamer Bio (GOSS) | 0.0 | $1.0M | 100k | 10.15 | |
| Revolution Medicines (RVMD) | 0.0 | $454k | 21k | 21.90 | |
| Gol Linhas Aereas Intlg S A spon adr p | 0.0 | $367k | 86k | 4.28 | |
| Eiger Biopharmaceuticals | 0.0 | $341k | 50k | 6.80 | |
| Phasebio Pharmaceuticals | 0.0 | $280k | 85k | 3.31 |
